Sanofi Showcases Long-Term Benefits Of Dupixent For Severe Asthma

Another Boost For Blockbuster

 
• By Kevin Grogan
  
inhaler
Dupixent reduced rates of severe asthma attacks in extension study • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Respiratory

More from Therapy Areas